Under-grading of <4 cm renal masses on renal biopsy.

Is there a role for neoadjuvant targeted therapy to downsize primary tumors for organ sparing strategies in renal cell carcinoma? Int J Surg Oncol (2012) 0.85

Re: under-grading of <4 cm renal masses on renal biopsy. J Urol (2012) 0.75

The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol (2004) 5.09

Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer (2008) 4.77

Population-based comparative effectiveness of nephron-sparing surgery vs ablation for small renal masses. BJU Int (2012) 2.81

Outcomes of active surveillance for men with intermediate-risk prostate cancer. J Clin Oncol (2010) 2.65

Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure). J Urol (2004) 2.23

Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance. J Clin Oncol (2011) 2.08

Imaging of retained surgical sponges in the abdomen and pelvis. AJR Am J Roentgenol (2003) 2.02

Multivariate analysis of risk factors for long-term urethroplasty outcome. J Urol (2009) 1.89

A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancer. J Urol (2012) 1.75

Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE. J Urol (2007) 1.70

How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate cancer? BJU Int (2013) 1.61

Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer. Cancer (2010) 1.60

Effect of obesity on urethroplasty outcome. Urology (2009) 1.59

The impact of serial prostate biopsies on sexual function in men on active surveillance for prostate cancer. J Urol (2012) 1.56

Evolving practice patterns for the management of small renal masses in the USA. BJU Int (2012) 1.55

Markov modeling of vasectomy reversal and ART for infertility: how do obstructive interval and female partner age influence cost effectiveness? Fertil Steril (2007) 1.50

Medical malpractice in American urology: 22-year national review of the impact of caps and implications for contemporary practice. J Urol (2008) 1.50

Re: H. Baumert et al. The use of polymer (Hem-o-lok) clips for management of the renal hilum during laparoscopic nephrectomy. Eur Urol 2006;49:816-9 and P.L. Steinberg et al. re: H. Baumert et al. The Use of Polymer (Hem-o-lok) clips for management of the renal hilum during laparascopic nephrectomy. Eur Urol 2006; 49:816-9. Eur Urol 2007;51:572-3. Eur Urol (2006) 1.39

Long-term outcomes and late complications of laparoscopic nephrectomy with renal autotransplantation. J Urol (2007) 1.39

Oncological and functional outcomes of radical cystectomy and orthotopic bladder replacement in women. Urology (2011) 1.39

The primary stone event: a new hypothesis involving a vascular etiology. J Urol (2004) 1.38

Outcomes and cost analysis of pyeloplasty for antenatally diagnosed ureteropelvic junction obstruction using Markov models. Urology (2008) 1.38

The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer. J Urol (2011) 1.23

Muconephrosis. Urology (2002) 1.22

Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE. J Urol (2006) 1.13

Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment. BJU Int (2011) 1.10

Treatment and outcome of invasive bladder cancer in patients after renal transplantation. J Urol (2004) 1.08

Laparoscopic linear cutting stapler failure. Urology (2002) 1.06

Differences in complications and outcomes for obese patients undergoing laparoscopic radical, partial or simple nephrectomy. J Urol (2004) 1.06

Risk of injury to adjacent organs with lower-pole fluoroscopically guided percutaneous nephrostomy: evaluation with prone, supine, and multiplanar reformatted CT. J Vasc Interv Radiol (2005) 1.05

Spatial ability, experience, and skill in laparoscopic surgery. Am J Surg (2004) 1.03

Natural history of untreated renal cell carcinoma with venous tumor thrombus. Urol Oncol (2012) 1.01

Decision analysis and Markov modeling in urology. J Urol (2007) 0.99

Laparoscopic management of peripelvic renal cysts: University of California, San Francisco, experience and review of literature. Urology (2005) 0.98

Precaval right renal arteries: prevalence and morphologic associations at spiral CT. Radiology (2004) 0.98

Simultaneous laparoscopic management of 3 urological malignancies. J Urol (2002) 0.97

Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancer. Urol Oncol (2009) 0.94

Sociodemographic characteristics and health related quality of life in men attending prostate cancer support groups. J Urol (2002) 0.94

Who is the average patient presenting with prostate cancer? Urology (2005) 0.93

Evaluation of the patient with hematuria. Med Clin North Am (2004) 0.92

Ureteral fibroepithelial polyp. J Ultrasound Med (2008) 0.92

Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer. BJU Int (2011) 0.91

Laparoscopic partial nephrectomy with temporary arterial occlusion: description of technique and renal functional outcomes. Urology (2004) 0.90

Increasing incidence of neuroblastoma and potentially higher associated mortality of children from nonmetropolitan areas: analysis of the surveillance, epidemiology, and end results database. J Pediatr Hematol Oncol (2009) 0.90

Prostate biopsy patterns in the CaPSURE database: evolution with time and impact on outcome after prostatectomy. J Urol (2007) 0.90

Changes in specific domains of sexual function and sexual bother after radical prostatectomy. BJU Int (2010) 0.88

Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes? J Clin Oncol (2010) 0.88

Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases. J Urol (2011) 0.87

Cost-utility analysis of treatment algorithms for moderate grade vesicoureteral reflux using Markov models. J Urol (2007) 0.86

Solitary fibrous tumor of the male pelvis: findings at CT with histopathologic correlation. Clin Imaging (2008) 0.86

Changes in cancer volume in serial biopsies of men on active surveillance for early stage prostate cancer. J Urol (2011) 0.85

Imaging clinically localized prostate cancer. Urol Clin North Am (2003) 0.85

Prostate cancer: reducing overtreatment: active surveillance in low-risk disease. Nat Rev Urol (2011) 0.84

Androgen deprivation use with external beam radiation for prostate cancer: results from CaPSURE. J Urol (2005) 0.84

Infections and urinary stone disease. Curr Pharm Des (2003) 0.84

Complete laparoscopic ileal cystoplasty. Urology (2002) 0.84

Novel microlaparoscopic technique for peritoneal dialysis catheter placement. Urology (2003) 0.83

Active surveillance for early-stage prostate cancer: defining the triggers for intervention. J Clin Oncol (2010) 0.83

Computed tomography and magnetic resonance imaging of adult renal cell carcinoma associated with Xp11.2 translocation. J Comput Assist Tomogr (2012) 0.83

Pure laparoscopic ileovesicostomy. J Urol (2003) 0.83

Role of active surveillance in the management of localized prostate cancer. J Natl Cancer Inst Monogr (2012) 0.83

Prostate cancer screening and treatment in the transplant population: current status and recommendations. J Urol (2009) 0.83

Laparoscopic right donor nephrectomy: a large single-center experience. Transplantation (2004) 0.83

Factors associated with surgery in patients with renal cell carcinoma and venous tumor thrombus. BJU Int (2010) 0.82

Detection of carbonic anhydrase-9 gene expression in peripheral blood cells predicts risk of disease recurrence in patients with renal cortical tumors. Urology (2006) 0.82

Upper quadrant access for urologic laparoscopy. Urology (2003) 0.81

Population based analysis of survival in patients with renal cell carcinoma and venous tumor thrombus. Urol Oncol (2011) 0.81

The role of active surveillance in the management of prostate cancer. J Natl Compr Canc Netw (2013) 0.81

Laparoscopic nephrectomy, ex vivo partial nephrectomy followed by allograft renal transplantation. Urology (2007) 0.79

Technique, indications and outcomes of pure laparoscopic right donor nephrectomy. J Urol (2004) 0.79

Benign prostate glandular tissue at radical prostatectomy surgical margins. Urology (2013) 0.79

Poor agreement of prostate specific antigen doubling times calculated using ultrasensitive versus standard prostate specific antigen values: important impact on risk assessment. J Urol (2011) 0.78

Failed percutaneous balloon dilation for renal access: incidence and risk factors. Urology (2005) 0.77

The effect of kidney morcellation on operative time, incision complications, and postoperative analgesia after laparoscopic nephrectomy. Int Braz J Urol (2006) 0.77

Pure laparoscopic right donor nephrectomy: step-by-step approach. J Endourol (2004) 0.77

Laparoscopic versus open cytoreductive nephrectomy in advanced renal-cell carcinoma. J Endourol (2006) 0.76

Risk of catecholamine crisis in patients undergoing resection of unsuspected pheochromocytoma. Int Braz J Urol (2011) 0.76

Editorial comment. J Urol (2012) 0.75

Commentary on "Radiofrequency ablation of incidental benign small renal mass: outcomes and follow-up protocol." Tan YK, Best SL, Olweny E, Park S, Trimmer C, Cadeddu JA, Department of Urology, University of Texas Southwestern Medical School, Dallas, Texas, TX. Urol Oncol (2013) 0.75

Commentary on "Benzodiazepine use possibly increases cancer risk: A population-based retrospective cohort study in Taiwan." Kao CH, Sun LM, Su KP, Chang SN, Sung FC, Muo CH, Liang JA, Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan.: J Clin Psychiatry 2012;73(4):e555-e60. Urol Oncol (2013) 0.75

Editorial comment. Urology (2010) 0.75

Comparison of nonabsorbable polymer ligating and standard titanium clips with and without a vascular cuff. J Endourol (2006) 0.75

Commentary on "Predicting the histology of small renal masses using preoperative dynamic contrast-enhanced magnetic resonance imaging." Kim JH, Bae JH, Lee KW, Kim ME, Park SJ, Park JY, Department of Urology, Soonchunhyang University Hospital, Seoul, Korea. Urol Oncol (2013) 0.75

Editorial comment. J Urol (2012) 0.75

Commentary on "Laparoendoscopic single-site (LESS) partial nephrectomy short-term outcomes." Rais-Bahrami S, George AK, Montag S, Okhunov Z, Richstone L, The Arthur Smith Institute for Urology, Hofstra North Shore-LIJ School of Medicine, New Hyde Park, NY: BJU Int 2012 (Epub ahead of print). Urol Oncol (2013) 0.75

Antidepressants and testicular cancer. Cancer Causes Control (2013) 0.75

Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes. PLoS One (2016) 0.75

Editorial comment. Urology (2011) 0.75

Re: Laparoscopic radical nephrectomy: incorporating the advantages of hand assisted and standard laparoscopy. J Urol (2003) 0.75

Editorial comment. Urology (2010) 0.75

Editorial comment. Urology (2013) 0.75

Editorial comment. Urology (2012) 0.75

Editorial comment. Urology (2012) 0.75

Economic analysis of infant vs postpubertal orchiopexy to prevent testicular cancer. Urology (2009) 0.75

Origin of urothelial carcinoma after renal transplant determined by fluorescence in situ hybridization. J Urol (2002) 0.75

Surgery for prostate cancer: rationale, technique and outcomes. Cancer Metastasis Rev (2002) 0.75